The global Human Immunodeficiency Virus (HIV) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Human Immunodeficiency Virus (HIV) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Human Immunodeficiency Virus (HIV) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Human Immunodeficiency Virus (HIV) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person cannot get rid of this virus properly but its effects can be reduced with the treatment.
This report aims to provide a comprehensive presentation of the global market for Human Immunodeficiency Virus (HIV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Immunodeficiency Virus (HIV). This report contains market size and forecasts of Human Immunodeficiency Virus (HIV) in global, including the following market information:
- Global Human Immunodeficiency Virus (HIV) Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The global HIV market is expected to grow in future due to decreasing HIV related death rates, low awareness of HIV transmission and government initiatives to promote HIV treatment. Key trends of this market include progressing HIV drug under pipeline, increasing adoption of STR and Development of technologically advanced diagnostic products. However, there are some factors which can hinder growth of the market including decreasing global HIV funds, social stigma and discrimination and treatment failures.
We surveyed the Human Immunodeficiency Virus (HIV) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Immunodeficiency Virus (HIV) Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Human Immunodeficiency Virus (HIV) Market Segment Percentages, by Type, 2022 (%)
Global Human Immunodeficiency Virus (HIV) Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Human Immunodeficiency Virus (HIV) Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Homecare Settings
- Others
Global Human Immunodeficiency Virus (HIV) Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Human Immunodeficiency Virus (HIV) Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Human Immunodeficiency Virus (HIV) revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Human Immunodeficiency Virus (HIV) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Gilead
- GlaxoSmithKline
- Johnson & Johnson
- Merck
- AbbVie
- Bristol-Myers Squibb
- Boehringer Ingelheim
- Genentech
- Cipla
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Immunodeficiency Virus (HIV), market overview.
Chapter 2: Global Human Immunodeficiency Virus (HIV) market size in revenue.
Chapter 3: Detailed analysis of Human Immunodeficiency Virus (HIV) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Immunodeficiency Virus (HIV) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Human Immunodeficiency Virus (HIV) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Immunodeficiency Virus (HIV) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Immunodeficiency Virus (HIV) Overall Market Size
2.1 Global Human Immunodeficiency Virus (HIV) Market Size: 2022 VS 2030
2.2 Global Human Immunodeficiency Virus (HIV) Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Human Immunodeficiency Virus (HIV) Players in Global Market
3.2 Top Global Human Immunodeficiency Virus (HIV) Companies Ranked by Revenue
3.3 Global Human Immunodeficiency Virus (HIV) Revenue by Companies
3.4 Top 3 and Top 5 Human Immunodeficiency Virus (HIV) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Human Immunodeficiency Virus (HIV) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Immunodeficiency Virus (HIV) Players in Global Market
3.6.1 List of Global Tier 1 Human Immunodeficiency Virus (HIV) Companies
3.6.2 List of Global Tier 2 and Tier 3 Human Immunodeficiency Virus (HIV) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Immunodeficiency Virus (HIV) Market Size Markets, 2022 & 2030
4.1.2 Diagnosis
4.1.3 Treatment
4.2 By Type - Global Human Immunodeficiency Virus (HIV) Revenue & Forecasts
4.2.1 By Type - Global Human Immunodeficiency Virus (HIV) Revenue, 2018-2023
4.2.2 By Type - Global Human Immunodeficiency Virus (HIV) Revenue, 2024-2030
4.2.3 By Type - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Immunodeficiency Virus (HIV) Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Diagnostic Centers
5.1.5 Homecare Settings
5.1.6 Others
5.2 By Application - Global Human Immunodeficiency Virus (HIV) Revenue & Forecasts
5.2.1 By Application - Global Human Immunodeficiency Virus (HIV) Revenue, 2018-2023
5.2.2 By Application - Global Human Immunodeficiency Virus (HIV) Revenue, 2024-2030
5.2.3 By Application - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Human Immunodeficiency Virus (HIV) Market Size, 2022 & 2030
6.2 By Region - Global Human Immunodeficiency Virus (HIV) Revenue & Forecasts
6.2.1 By Region - Global Human Immunodeficiency Virus (HIV) Revenue, 2018-2023
6.2.2 By Region - Global Human Immunodeficiency Virus (HIV) Revenue, 2024-2030
6.2.3 By Region - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Human Immunodeficiency Virus (HIV) Revenue, 2018-2030
6.3.2 US Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.3.3 Canada Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.3.4 Mexico Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Human Immunodeficiency Virus (HIV) Revenue, 2018-2030
6.4.2 Germany Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.4.3 France Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.4.4 U.K. Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.4.5 Italy Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.4.6 Russia Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.4.7 Nordic Countries Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.4.8 Benelux Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Human Immunodeficiency Virus (HIV) Revenue, 2018-2030
6.5.2 China Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.5.3 Japan Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.5.4 South Korea Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.5.5 Southeast Asia Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.5.6 India Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Human Immunodeficiency Virus (HIV) Revenue, 2018-2030
6.6.2 Brazil Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.6.3 Argentina Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Human Immunodeficiency Virus (HIV) Revenue, 2018-2030
6.7.2 Turkey Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.7.3 Israel Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.7.4 Saudi Arabia Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.7.5 UAE Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
7 Human Immunodeficiency Virus (HIV) Companies Profiles
7.1 Gilead
7.1.1 Gilead Company Summary
7.1.2 Gilead Business Overview
7.1.3 Gilead Human Immunodeficiency Virus (HIV) Major Product Offerings
7.1.4 Gilead Human Immunodeficiency Virus (HIV) Revenue in Global Market (2018-2023)
7.1.5 Gilead Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Human Immunodeficiency Virus (HIV) Major Product Offerings
7.2.4 GlaxoSmithKline Human Immunodeficiency Virus (HIV) Revenue in Global Market (2018-2023)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Human Immunodeficiency Virus (HIV) Major Product Offerings
7.3.4 Johnson & Johnson Human Immunodeficiency Virus (HIV) Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Human Immunodeficiency Virus (HIV) Major Product Offerings
7.4.4 Merck Human Immunodeficiency Virus (HIV) Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 AbbVie
7.5.1 AbbVie Company Summary
7.5.2 AbbVie Business Overview
7.5.3 AbbVie Human Immunodeficiency Virus (HIV) Major Product Offerings
7.5.4 AbbVie Human Immunodeficiency Virus (HIV) Revenue in Global Market (2018-2023)
7.5.5 AbbVie Key News & Latest Developments
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Company Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Major Product Offerings
7.6.4 Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Revenue in Global Market (2018-2023)
7.6.5 Bristol-Myers Squibb Key News & Latest Developments
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Company Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Major Product Offerings
7.7.4 Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Revenue in Global Market (2018-2023)
7.7.5 Boehringer Ingelheim Key News & Latest Developments
7.8 Genentech
7.8.1 Genentech Company Summary
7.8.2 Genentech Business Overview
7.8.3 Genentech Human Immunodeficiency Virus (HIV) Major Product Offerings
7.8.4 Genentech Human Immunodeficiency Virus (HIV) Revenue in Global Market (2018-2023)
7.8.5 Genentech Key News & Latest Developments
7.9 Cipla
7.9.1 Cipla Company Summary
7.9.2 Cipla Business Overview
7.9.3 Cipla Human Immunodeficiency Virus (HIV) Major Product Offerings
7.9.4 Cipla Human Immunodeficiency Virus (HIV) Revenue in Global Market (2018-2023)
7.9.5 Cipla Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Human Immunodeficiency Virus (HIV) Market Opportunities & Trends in Global Market
Table 2. Human Immunodeficiency Virus (HIV) Market Drivers in Global Market
Table 3. Human Immunodeficiency Virus (HIV) Market Restraints in Global Market
Table 4. Key Players of Human Immunodeficiency Virus (HIV) in Global Market
Table 5. Top Human Immunodeficiency Virus (HIV) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Human Immunodeficiency Virus (HIV) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Human Immunodeficiency Virus (HIV) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Human Immunodeficiency Virus (HIV) Product Type
Table 9. List of Global Tier 1 Human Immunodeficiency Virus (HIV) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Immunodeficiency Virus (HIV) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Human Immunodeficiency Virus (HIV) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Human Immunodeficiency Virus (HIV) Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Human Immunodeficiency Virus (HIV) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Human Immunodeficiency Virus (HIV) Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Human Immunodeficiency Virus (HIV) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Human Immunodeficiency Virus (HIV) Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2024-2030
Table 30. Gilead Company Summary
Table 31. Gilead Human Immunodeficiency Virus (HIV) Product Offerings
Table 32. Gilead Human Immunodeficiency Virus (HIV) Revenue (US$, Mn) & (2018-2023)
Table 33. Gilead Key News & Latest Developments
Table 34. GlaxoSmithKline Company Summary
Table 35. GlaxoSmithKline Human Immunodeficiency Virus (HIV) Product Offerings
Table 36. GlaxoSmithKline Human Immunodeficiency Virus (HIV) Revenue (US$, Mn) & (2018-2023)
Table 37. GlaxoSmithKline Key News & Latest Developments
Table 38. Johnson & Johnson Company Summary
Table 39. Johnson & Johnson Human Immunodeficiency Virus (HIV) Product Offerings
Table 40. Johnson & Johnson Human Immunodeficiency Virus (HIV) Revenue (US$, Mn) & (2018-2023)
Table 41. Johnson & Johnson Key News & Latest Developments
Table 42. Merck Company Summary
Table 43. Merck Human Immunodeficiency Virus (HIV) Product Offerings
Table 44. Merck Human Immunodeficiency Virus (HIV) Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Key News & Latest Developments
Table 46. AbbVie Company Summary
Table 47. AbbVie Human Immunodeficiency Virus (HIV) Product Offerings
Table 48. AbbVie Human Immunodeficiency Virus (HIV) Revenue (US$, Mn) & (2018-2023)
Table 49. AbbVie Key News & Latest Developments
Table 50. Bristol-Myers Squibb Company Summary
Table 51. Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Product Offerings
Table 52. Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Revenue (US$, Mn) & (2018-2023)
Table 53. Bristol-Myers Squibb Key News & Latest Developments
Table 54. Boehringer Ingelheim Company Summary
Table 55. Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Product Offerings
Table 56. Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Revenue (US$, Mn) & (2018-2023)
Table 57. Boehringer Ingelheim Key News & Latest Developments
Table 58. Genentech Company Summary
Table 59. Genentech Human Immunodeficiency Virus (HIV) Product Offerings
Table 60. Genentech Human Immunodeficiency Virus (HIV) Revenue (US$, Mn) & (2018-2023)
Table 61. Genentech Key News & Latest Developments
Table 62. Cipla Company Summary
Table 63. Cipla Human Immunodeficiency Virus (HIV) Product Offerings
Table 64. Cipla Human Immunodeficiency Virus (HIV) Revenue (US$, Mn) & (2018-2023)
Table 65. Cipla Key News & Latest Developments
List of Figures
Figure 1. Human Immunodeficiency Virus (HIV) Segment by Type in 2022
Figure 2. Human Immunodeficiency Virus (HIV) Segment by Application in 2022
Figure 3. Global Human Immunodeficiency Virus (HIV) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Immunodeficiency Virus (HIV) Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Human Immunodeficiency Virus (HIV) Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Human Immunodeficiency Virus (HIV) Revenue in 2022
Figure 8. By Type - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 9. By Application - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 10. By Type - Global Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 12. By Application - Global Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 14. By Region - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 15. By Country - North America Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 16. US Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 20. Germany Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 21. France Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 28. China Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 32. India Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 34. Brazil Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 37. Turkey Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 41. Gilead Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GlaxoSmithKline Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Johnson & Johnson Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. AbbVie Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Genentech Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Cipla Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
